These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9118608)

  • 1. Osteoporosis and vertebral collapse following low-dose, low molecular weight heparin therapy in a young patient.
    Sivakumaran M; Ghosh K; Zaidi Y; Hutchinson RM
    Clin Lab Haematol; 1996 Mar; 18(1):55-7. PubMed ID: 9118608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged low-molecular-weight heparin use during pregnancy and subsequent bone mineral density.
    Galambosi P; Hiilesmaa V; Ulander VM; Laitinen L; Tiitinen A; Kaaja R
    Thromb Res; 2016 Jul; 143():122-6. PubMed ID: 27236710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimising the risk of heparin-induced osteoporosis during pregnancy.
    Hawkins D; Evans J
    Expert Opin Drug Saf; 2005 May; 4(3):583-90. PubMed ID: 15934862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of unfractionated heparin and low molecular weight heparins in pregnancy.
    Casele HL
    Clin Obstet Gynecol; 2006 Dec; 49(4):895-905. PubMed ID: 17082684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy-related osteoporotic vertebral compression fractures in two patients treated with low-molecular-weight heparin during pregnancy: case reports.
    Ozturk G; Akpinar P; Karamanlioglu AD; Ozkan FU; Aktas I
    Gynecol Endocrinol; 2018 May; 34(5):378-380. PubMed ID: 29069943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in bone density during long-term administration of low-molecular-weight heparins or acenocoumarol for secondary prophylaxis of venous thromboembolism.
    Wawrzyńska L; Tomkowski WZ; Przedlacki J; Hajduk B; Torbicki A
    Pathophysiol Haemost Thromb; 2003; 33(2):64-7. PubMed ID: 14624046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long-term low-molecular-weight heparin therapy during pregnancy: is there a bone risk?].
    Khalifa P; Marie-Scemama L
    Therapie; 2013; 68(1):37-42. PubMed ID: 23484659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review: Low-molecular-weight heparin-induced osteoporosis and osteoporotic fractures: a myth or an existing entity?
    Lefkou E; Khamashta M; Hampson G; Hunt BJ
    Lupus; 2010 Jan; 19(1):3-12. PubMed ID: 19934178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of low-molecular-weight heparin compared to unfractionated heparin in hemodialysis: a systematic review and meta-analysis.
    Lazrak HH; René É; Elftouh N; Leblanc M; Lafrance JP
    BMC Nephrol; 2017 Jun; 18(1):187. PubMed ID: 28592259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postpartum bone mineral density in women treated for thromboprophylaxis with unfractionated heparin or LMW heparin.
    Pettilä V; Leinonen P; Markkola A; Hiilesmaa V; Kaaja R
    Thromb Haemost; 2002 Feb; 87(2):182-6. PubMed ID: 11858475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of antithrombotic drugs on bone health.
    Dadwal G; Schulte-Huxel T; Kolb G
    Z Gerontol Geriatr; 2020 Aug; 53(5):457-462. PubMed ID: 31414167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of heparin and low molecular weight heparins on bone.
    Rajgopal R; Bear M; Butcher MK; Shaughnessy SG
    Thromb Res; 2008; 122(3):293-8. PubMed ID: 17716711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-molecular-weight heparin (LMWH) in the treatment of thrombosis.
    Holzheimer RG
    Eur J Med Res; 2004 Apr; 9(4):225-39. PubMed ID: 15210403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep venous thrombosis and pulmonary embolism. Part 1. Initial treatment: usually a low-molecular-weight heparin.
    Prescrire Int; 2013 Apr; 22(137):99-101, 103-4. PubMed ID: 23662321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Secondary anticoagulant prophylaxis with low molecular heparins or oral anticoagulants and bone mineral density].
    Wawrzyńska L; Przedlacki J; Hajduk B; Tomkowski W; Fijałkowska A; Ostrowski K; Torbicki A
    Pol Arch Med Wewn; 2000 Nov; 104(5):769-77. PubMed ID: 11434089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry.
    Spyropoulos AC; Turpie AG; Dunn AS; Spandorfer J; Douketis J; Jacobson A; Frost FJ;
    J Thromb Haemost; 2006 Jun; 4(6):1246-52. PubMed ID: 16706967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low molecular weight heparin-induced skin necrosis-a systematic review.
    Handschin AE; Trentz O; Kock HJ; Wanner GA
    Langenbecks Arch Surg; 2005 Jun; 390(3):249-54. PubMed ID: 15570433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low molecular weight heparin and pregnancy.
    Prescrire Int; 2001 Oct; 10(55):147-9. PubMed ID: 11824430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Secondary osteoporosis induced by anticoagulants?].
    Riess H; Loew A; Himmelreich G
    Orthopade; 2001 Jul; 30(7):451-5. PubMed ID: 11515183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin-induced spinal fractures.
    Squires JW; Pinch LW
    JAMA; 1979 Jun; 241(22):2417-8. PubMed ID: 439319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.